Enzymotec Ltd. : Ingredients - Company Profile, SWOT & Financial Analysis

Market: Ingredients

Israel, 43 pages report, published by Canadean

Keywords : Enzymotec Ltd. , Israel, Ingredients, Canadean, company overview, key facts, business description, SWOT analysis, strengths, weaknesses, opportunities, threats, mergers & acquisitions, key employees, competitive benchmarking, employee biographies & locat

Report ThumbnailOctober-2016
Summary
Canadean's "Enzymotec Ltd. : Ingredients - Company Profile, SWOT & Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, mergers & acquisitions, recent developments, key employees, company locations and subsidiaries as well as competitive benchmarking data.

Key Findings
This report is a crucial resource for industry executives and anyone looking to access key information about "Enzymotec Ltd. "

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Canadean strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Synopsis
Enzymotec Ltd., (Enzymotec) develops, manufactures and markets nutritional ingredients and medical foods in Israel. The company offers wide range of lipid based products, such as lipid based medicines, lipid compositions for infant formula and bioactive ingredients for the pharmaceutical and nutritional industries. Enzymotec partners with pharmaceutical companies such as AAK, Elder, DKSH, Teva Pharmaceutical, PFM medical, Daiichi Sankyo, Inc and Sechang Int'l Corp. Its operations are spread in several countries across North America, Europe, Australia, Oceania, the Middle East and Asia. The company also operates research and development, and production facilities in Northern Israel. Enzymotec is headquartered in Migdal Ha'Emeq, Israel.

- This business intelligence report presents the key company information, essential to understanding industry challenges and competitors.

- The SWOT analysis identifies the company’s strengths, weaknesses, opportunities for growth and threats. The key competitors are dissected alongside the larger challenges that the industry is facing.

- The company profile relays all current information about the business operations, including key employees, major products and services, company history, locations and subsidiaries alongside a supporting statement from the Chairman and Managing Director.

Reasons To Buy
- Quickly enhance your understanding of "Enzymotec Ltd. "

- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.

- Increase business/sales activities by understanding your competitors’ businesses better.

- Recognize potential partnerships and suppliers.

Key Highlights
Enzymotec Ltd., (Enzymotec) develops, manufactures and markets nutritional ingredients and medical foods in Israel. The company offers wide range of lipid based products, such as lipid based medicines, lipid compositions for infant formula and bioactive ingredients for the pharmaceutical and nutritional industries. Enzymotec partners with pharmaceutical companies such as AAK, Elder, DKSH, Teva Pharmaceutical, PFM medical, Daiichi Sankyo, Inc and Sechang Int'l Corp. Its operations are spread in several countries across North America, Europe, Australia, Oceania, the Middle East and Asia. The company also operates research and development, and production facilities in Northern Israel. Enzymotec is headquartered in Migdal Ha'Emeq, Israel.
  • Figure 1: Enzymotec Ltd. - Revenue and Operating Profit
  • Figure 2: Enzymotec Ltd. - Asset and Liabilities
  • Figure 3: Enzymotec Ltd. - Operational Efficiency
  • Figure 4: Enzymotec Ltd. - Solvency
  • Figure 5: Enzymotec Ltd. - Valuation
  • Figure 6: Enzymotec Ltd. - Market Capitalization
  • Figure 7: Enzymotec Ltd. - Efficiency
  • Figure 8: Enzymotec Ltd. - Valuation
  • Figure 9: Enzymotec Ltd. - Turnover: Inventory and Asset
  • Table 1: Enzymotec Ltd. - Key Employees
  • Table 2: Enzymotec Ltd. - Key Employees Biographies
  • Table 3: Enzymotec Ltd. - Major Products and Services
  • Table 4: Enzymotec Ltd. - History
  • Table 5: Enzymotec Ltd. - Subsidiaries
  • Table 6: Enzymotec Ltd. - Annual ratios
  • Table 7: Enzymotec Ltd. - Interim ratios
  • Table 8: Enzymotec Ltd. - Capital Market Ratios
  • 1 Enzymotec Ltd.
  • 2 Enzymotec Ltd. - Key Employees
  • 3 Enzymotec Ltd. - Key Employees Biographies
  • 4 Enzymotec Ltd. - Major Products and Services
  • 5 Enzymotec Ltd. - History
  • 6 Enzymotec Ltd. - Company Statement
  • 7 Enzymotec Ltd. - Locations and Subsidiaries
  • 7.1 Enzymotec Ltd. - Head Office
  • 7.2 Enzymotec Ltd. - Other Locations and Subsidiaries
  • 8 Enzymotec Ltd. - Business Analysis
  • 8.1 Enzymotec Ltd. - Company Overview
  • 8.2 Enzymotec Ltd. - Business Description
  • 9 Enzymotec Ltd. - SWOT Analysis
  • 9.1 Enzymotec Ltd. - SWOT Analysis - Overview
  • 9.2 Enzymotec Ltd. - Strengths
  • 9.2.1 Strength - Strong Alliance
  • 9.2.2 Strength - Focus on Quality
  • 9.2.3 Strength - Focus on Research and Development
  • 9.3 Enzymotec Ltd. - Weaknesses
  • 9.3.1 Weakness - Decreasing Profitability
  • 9.3.2 Weakness - Narrow Product Portfolio
  • 9.4 Enzymotec Ltd. - Opportunities
  • 9.4.1 Opportunity - Upsurge of Lifestyle Diseases
  • 9.4.2 Opportunity - Positive Outlook for the Global Pharmaceutical Industry
  • 9.4.3 Opportunity - Growing Global Functional Food Market
  • 9.5 Enzymotec Ltd. - Threats
  • 9.5.1 Threat - Stringent Regulations
  • 9.5.2 Threat - Environmental Concerns
  • 9.5.3 Threat - Foreign Exchange Risks
  • 10 Enzymotec Ltd. - Company Financial Analysis
  • 10.1 Enzymotec Ltd. - Five Year Snapshot: Overview of Financial and Operational Performance Indicators
  • 11 Enzymotec Ltd. - Interim ratios
  • 11.1.1 Enzymotec Ltd. - Financial ratios: Capital Market Ratios
  • 11.2 Enzymotec Ltd. - Financial Performance and Ratio Charts
  • 11.2.1 Enzymotec Ltd. - Revenue and Operating margin
  • 11.2.2 Enzymotec Ltd. - Asset and Liabilities
  • 11.2.3 Enzymotec Ltd. - Operational Efficiency
  • 11.2.4 Enzymotec Ltd. - Solvency
  • 11.2.5 Enzymotec Ltd. - Valuation
  • 11.3 Enzymotec Ltd. - Competitive Benchmarking
  • 11.3.1 Enzymotec Ltd. - Market Capitalization
  • 11.3.2 Enzymotec Ltd. - Efficiency
  • 11.3.3 Enzymotec Ltd. - Valuation
  • 11.3.4 Enzymotec Ltd. - Turnover: Inventory and Asset
  • 12 Enzymotec Ltd. - Mergers & Acquisitions and Partnerships
  • 12.1 Enzymotec Ltd. - M&A and Partnerships Strategy
  • 13 Enzymotec Ltd. - Recent Developments
  • 14 Appendix
  • 14.1 Methodology
  • 14.2 Enzymotec Ltd. - Ratio Definitions
  • 14.3 Disclaimer

Please select a license type

Share

Related Products

CanadeanEnzymotec Ltd. : Ingredients - Company Profile, SWOT & Financial AnalysisProduct ThumbnailEnzymotec Ltd. : Ingredients - Company Profile, SWOT & Financial Analysis, Company ReportProduct #: 578761
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved